Schonfeld Strategic Advisors’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5
| Closed | -$28.8K | – | 1862 |
|
|
2023
Q4 | $28.8K | Buy |
5
+1
| +25% | +$5.76K | ﹤0.01% | 1600 |
|
|
2023
Q3 | $47.1K | Hold |
4
| – | – | ﹤0.01% | 1399 |
|
|
2023
Q2 | $211K | Hold |
4
| – | – | ﹤0.01% | 1480 |
|
|
2023
Q1 | $293K | Hold |
4
| – | – | ﹤0.01% | 1355 |
|
|
2022
Q4 | $330K | Sell |
4
-1
| -20% | -$82.4K | ﹤0.01% | 1725 |
|
|
2022
Q3 | $447K | Buy |
5
+1
| +25% | +$89.4K | ﹤0.01% | 1799 |
|
|
2022
Q2 | $524K | Sell |
4
-1
| -20% | -$131K | 0.01% | 1267 |
|
|
2022
Q1 | $869K | Hold |
5
| – | – | 0.01% | 1005 |
|
|
2021
Q4 | $1.23M | Buy |
+5
| New | +$1.23M | 0.01% | 779 |
|
|
2021
Q2 | – | Hold |
0
| – | -$296K | – | 1875 |
|
|
2021
Q1 | – | Hold |
0
| – | -$407K | – | 1289 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1070 |
|